Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: BWAC who wrote (2512)	2/16/1999 10:03:00 AM
From: KLH	Respond to of 2553

Well, at least I can now get quotes under the old symbol. My buy orders aren't on my screen though. All orders must go manual. :^(

To: BWAC who wrote (2512)	2/16/1999 10:29:00 AM
From: BWAC	Read Replies (1) \| Respond to of 2553

DATE: February 16, 1999 Genzyme Tissue Repair (Nasdaq:GZTR) announced today that it has changed its ticker symbol to GZTR from GENZL. The stock will continue to trade on the Nasdaq National Market. This change has been made in response to shareholder concerns regarding the similarity of Genzyme Tissue Repair's old ticker symbol, GENZL, and Genzyme General's ticker symbol, GENZ. Because a five-letter ticker symbol is not compatible with all systems that publish stock quotes, confusion arose when GENZL was sometimes shortened to GENZ. Genzyme Tissue Repair anticipates that the new ticker, GZTR, will more readily differentiate its stock for shareholders. Genzyme Tissue Repair is a leading developer of biological products for the treatment of orthopedic injuries such as cartilage damage, and severe burns. It is a division of Genzyme Corp. and has its own common stock intended to reflect its value and track its performance. ---------- Please call Genzyme's Corporate Communications department at 1-617-252-7570 for additional information.